4/A
Changes in Ownership
Niagen Bioscience, Inc. Filed Acc 0001415889-20-002558
Options or other derivatives
- CHIEF FINANCIAL OFFICER acquired 109,054 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
FARR KEVIN M · CHIEF FINANCIAL OFFICER
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-02-25 | Grant or award : show line 1 in the form Employee Stock Options (right to buy) | +109,054 | 109,054 | D |
Loading xslF345X03/form4a-11062020_011146.xml…